Accuray reported a solid performance in Q4 2020, with gross orders of $94.3 million and net revenue of $95.0 million. The company generated $19.2 million in operating cash flow and ended the quarter with $108.6 million in cash and short-term restricted cash. Despite a net loss of $0.8 million, Adjusted EBITDA was $9.3 million. The company's ending backlog increased by 22 percent from the prior year.
Gross orders of $94.3 million, including 8 orders from China.
Net revenue of $95.0 million, net loss of $0.8 million, Adjusted EBITDA of $9.3 million.
Generated $19.2 million of operating cash flow and ended the quarter with $108.6 million of cash and short-term restricted cash.
Shipped nine Synchrony upgrades.
Accuray believes it is prudent to refrain from providing revenue and adjusted EBITDA guidance for fiscal year 2021 due to the continued evolution of the COVID-19 pandemic and the uncertainty surrounding its impact on the global economy and the healthcare industry.
Visualization of income flow from segment revenue to net income